Sofinnova Investments, Inc. Cogent Biosciences, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.36 Billion
- Q1 2025
A detailed history of Sofinnova Investments, Inc. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 2,182,121 shares of COGT stock, worth $16.4 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
2,182,121
Previous 823,160
165.09%
Holding current value
$16.4 Million
Previous $6.42 Million
103.58%
% of portfolio
0.96%
Previous 0.52%
Shares
6 transactions
Others Institutions Holding COGT
# of Institutions
196Shares Held
116MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$68.4 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$67.3 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$66.8 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$54.7 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$52.3 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $494M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...